Predictive Oncology Inc.
Price Action
Technical Summary
WEAKENINGPredictive Oncology Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 86), indicating clear outperformance against the broad market. Earnings contraction of 221% provides fundamental context to the price action. However, price is extended 96% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.29 | +49.15% | ABOVE |
| 50 SMA | $2.51 | +95.65% | ABOVE |
| 100 SMA | $4.04 | +21.55% | ABOVE |
| 150 SMA | $6.29 | -21.89% | BELOW |
| 200 SMA | $7.88 | -37.70% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is POAI in an uptrend right now?
POAI has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is POAI overbought or oversold?
POAI's RSI (14) is 66. The stock is in neutral territory, neither overbought nor oversold.
Is POAI outperforming the market?
POAI has a Relative Strength (RS) Rating of 86 out of 99. Yes, POAI is a market leader, outperforming 86% of all stocks over the past 12 months.
Where is POAI in its 52-week range?
POAI is trading at $4.91, which is 15% of its 52-week high ($32.10) and 12% above its 52-week low ($1.03).
How volatile is POAI?
POAI has a Beta of 1.92 and 52-week volatility of 180%. It's more volatile than the S&P 500 - expect bigger swings.